Dr. Tory Spindle, Using human laboratory studies to advance cannabis regulatory science

May 2023

Dr. Tory Spindle obtained his PhD in Experimental Health Psychology from Virginia Commonwealth University. Broadly, Dr. Spindle utilizes human laboratory studies to characterize the behavioral pharmacology of cannabis and individual cannabis constituents. His research seeks to understand how factors such as route of administration (oral, vaped, smoked, topical), dose, product formulation/chemical composition profile, and user factors (e.g., puffing topography, sex, tolerance) impacts the pharmacokinetic and pharmacodynamic effects of cannabis. Another emphasis of his work is on characterizing cognitive, psychomotor, and driving impairment associated with cannabis, when used alone and in combination with alcohol. Overall, Dr. Spindle’s work is intended to inform policy decisions involving cannabis such as product standards and accessibility, dosing guidelines, and procedures for detecting cannabis impairment. Because the overarching goal of his research is to inform policies and regulatory actions for cannabis, his work can be best described as “cannabis regulatory science.”

Previous Webinars

TBA

The next Plant Science and Cultivation Series Webinar will be held in May. Please stay tuned!

Read More »

Andrew Kesner, PhD

Preclinical modeling of spontaneous Δ-9-THC withdrawal symptoms in mice: sleep, dopamine, and behavioral maladaptations

April 10th, 1:00PM MST

Dr. Kesner is the Chief of the Unit on Motivation and Arousal at National Institute on Alcohol Abuse and Alcoholism (NIAAA). The mission of his lab is to use systems neuroscience approaches to understand how brain systems controlling motivated […]

Read More »

Roberta Paris, PhD.

Genetic, molecular and biochemical studies on the accumulation of bioactive compounds in Cannabis sativa L.

19 March, 2025, 11:00 AM  

Dr. Roberta Paris studied at the Alma Mater Studiorum, University of Bologna, where she obtained the PhD in Cellular and Molecular Biology in 2006. She is a permanent researcher at Council for Agricultural Research and Economic, Research […]

Read More »

Sarah D. Lichenstein, PhD.

Neural mechanisms of risk for problem-level cannabis use among emerging adults

Dr. Lichenstein is a licensed clinical psychologist, an Assistant Professor of Psychiatry, and Assistant Director of the Yale Imaging and Psychopharmacology Lab at Yale School of Medicine. She received her BA in Psychology from Bard College (2008), and her PhD in Clinical Psychology from the […]

Read More »

Kevin Boehnke, PHD.

January 9th at 1:00PM MST

Thoughtful approaches to chronic pain and cannabis research

Dr. Kevin Boehnke is an Assistant Professor in the Department of Anesthesiology and the Chronic Pain and Fatigue Research Center. Kevin received his doctorate from the University of Michigan School of Public Health in Environmental Health Sciences in 2017. He is also a […]

Read More »

David Gorelick, MD, PHD.

December 12th at 1:00PM MST

Cannabis-related psychiatric disorders

Dr. David Gorelick earned his bachelor degree in psychology from Cornell University and his medical degree and PhD in pharmacology from Albert Einstein College of Medicine. After completing his psychiatry residency at UCLA, he remained on the faculty until 1989, when he moved to the NIDA Intramural Research […]

Read More »